Fool.com
Get smart. Have fun. Make money.
Results 31 - 40 of 58 : Previous 1 2 3 4 5 6 Next
NeurogesX Gets a Painful Kick in the Pants
NeurogesX's lead drug fails in clinical testing.
Endo releases its 2007 financial results.
Alpharma Doing Its Best Endo Imitation
Alpharma sells one of its business units.
Eli Lilly may be close to resolving a government lawsuit over improper marketing.
Alexza and Endo ink a partnership deal.
The generics drugmaker forecasts its 2008 financials.
The drugmaker releases its third-quarter financial results.
Things look good despite some setbacks.
The drug developer keeps focused on relieving pain.
Sales of the multiple sclerosis drug are picking up, but probably can't grow into the stock's valuation.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK